Ignite Creation Date:
2025-12-25 @ 12:45 AM
Ignite Modification Date:
2026-01-07 @ 5:47 PM
Study NCT ID:
NCT01848067
Status:
COMPLETED
Last Update Posted:
2025-05-04
First Post:
2013-05-03
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Alisertib, Abiraterone Acetate and Prednisone in Treating Patients With Hormone-Resistant Prostate Cancer
Sponsor:
Sidney Kimmel Cancer Center at Thomas Jefferson University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-08-14
Start Date Type:
ACTUAL
Primary Completion Date:
2015-03-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-06-23
Completion Date Type:
ACTUAL
First Submit Date:
2013-05-03
First Submit QC Date:
None
Study First Post Date:
2013-05-07
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-11-08
Results First Submit QC Date:
None
Results First Post Date:
2017-12-06
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-05-01
Last Update Post Date:
2025-05-04
Last Update Post Date Type:
ACTUAL